These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3090342)

  • 21. Anti-tuberculosis activity of some N-pentopyranosylamines.
    Moczulska A
    Acta Pol Pharm; 2004; 61(4):259-62. PubMed ID: 15575591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis.
    Bapela NB; Lall N; Fourie PB; Franzblau SG; Van Rensburg CE
    Phytomedicine; 2006 Nov; 13(9-10):630-5. PubMed ID: 16987644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synergic activity of lysozyme in combination with antituberculous agents. I. Inhibitory activity against M. tuberculosis in vitro and synergic effect in vivo measured by S.S.A.A.T. method].
    Tsukiori N; Sasaki S; Takahashi T; Fukuda A
    Kekkaku; 1965 Dec; 40(12):555-9. PubMed ID: 4957405
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.
    Tan CK; Lai CC; Liao CH; Chou CH; Hsu HL; Huang YT; Hsueh PR
    J Antimicrob Chemother; 2009 Aug; 64(2):428-9. PubMed ID: 19454523
    [No Abstract]   [Full Text] [Related]  

  • 25. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
    Showalter HD; Denny WA
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 27. Preclinical testing of new drugs for tuberculosis: current challenges.
    Lenaerts AJ; Degroote MA; Orme IM
    Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antitubercular screening of imidazole derivatives.
    Pandey J; Tiwari VK; Verma SS; Chaturvedi V; Bhatnagar S; Sinha S; Gaikwad AN; Tripathi RP
    Eur J Med Chem; 2009 Aug; 44(8):3350-5. PubMed ID: 19272678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on pyrazine derivatives. XVI. Antitubercular properties of compound F-369 in in vitro and in vivo studies].
    Janowiec M; Marczewska J; Stambrowska A; Foks H; Pancechowska-Ksepko D; Wrześniowska K
    Pneumonol Pol; 1985 Jan; 53(1):9-14. PubMed ID: 3925442
    [No Abstract]   [Full Text] [Related]  

  • 30. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains].
    Tsukamura M
    Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312
    [No Abstract]   [Full Text] [Related]  

  • 31. Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents.
    Prado S; Ledeit H; Michel S; Koch M; Darbord JC; Cole ST; Tillequin F; Brodin P
    Bioorg Med Chem; 2006 Aug; 14(15):5423-8. PubMed ID: 16616504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
    Sayğan MB; Ocak F; Cesur S; Tarhan G; Ceyhan I; Gümüişlü F; Beker G; Güner U; Coşkun E
    Mikrobiyol Bul; 2007 Jul; 41(3):403-9. PubMed ID: 17933251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
    Ausina Ruiz V; Lonca Giménez J
    Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isolation of mutants resistant to antituberculous drugs in wild strains of M. bovis].
    de Kantor IN; Lesslie IW
    Medicina (B Aires); 1974; 34(3):244-8. PubMed ID: 4212693
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of the susceptibility to major and minor drugs of tubercle bacilli isolated from 100 consecutive patients never treated with minor drugs.
    Tan THIAM HOK ; The KIE SENG ; Yang SHE YEN ; Tan LIOE SAN
    Paediatr Indones; 1966; 6(2):71-4. PubMed ID: 4960067
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanism of action "in vitro" and "in vivo" of antitubercular drugs].
    Gialdroni-Grassi G
    G Ital Chemioter; 1966; 13(1):11-26. PubMed ID: 4967319
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative data on the determination of the resistance of tuberculosis mycobacteria to the major antitubercular agents on various dense media].
    Smolianskaia AZ; Moreĭn EM
    Lab Delo; 1966; 4():227-9. PubMed ID: 4170335
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the sensitivity of a rapidly growing Mycobacterium strain H-7, to antitubercular drugs].
    Ishiguro S
    Kekkaku; 1967 Oct; 42(10):413-6. PubMed ID: 4966679
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison between antituberculous activity of alpha-ethyl-thioisonicotinamide (1314 TH) and alpha-N-propylthioisonicotinamide (1321 TH) in vitro].
    Tamura M; Takano S
    Kekkaku; 1971 May; 46(5):137-52. PubMed ID: 4996120
    [No Abstract]   [Full Text] [Related]  

  • 40. Antituberculous activity of some aryl semicarbazone derivatives.
    Sriram D; Yogeeswari P; Thirumurugan R
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3923-4. PubMed ID: 15225698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.